These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 7585544
1. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations. Müller JR, Janz S, Potter M. Cancer Res; 1995 Nov 01; 55(21):5012-8. PubMed ID: 7585544 [Abstract] [Full Text] [Related]
2. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Bhatia K, Huppi K, Spangler G, Siwarski D, Iyer R, Magrath I. Nat Genet; 1993 Sep 01; 5(1):56-61. PubMed ID: 8220424 [Abstract] [Full Text] [Related]
4. Illegitimate recombinations between c-myc and immunoglobulin loci are remodeled by deletions in mouse plasmacytomas but not in Burkitt's lymphomas. Müller JR, Janz S, Potter M. Curr Top Microbiol Immunol; 1995 Sep 01; 194():425-9. PubMed ID: 7895518 [Abstract] [Full Text] [Related]
5. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice. Park SS, Kim JS, Tessarollo L, Owens JD, Peng L, Han SS, Tae Chung S, Torrey TA, Cheung WC, Polakiewicz RD, McNeil N, Ried T, Mushinski JF, Morse HC, Janz S. Cancer Res; 2005 Feb 15; 65(4):1306-15. PubMed ID: 15735016 [Abstract] [Full Text] [Related]
13. Aberrant class switching juxtaposes c-myc with a middle repetitive element (LINE) and an IgH intron in two spontaneously arising rat immunocytomas. Pear WS, Nelson SF, Axelson H, Wahlström G, Bazin H, Klein G, Sümegi J. Oncogene; 1988 May 15; 2(5):499-507. PubMed ID: 3131719 [Abstract] [Full Text] [Related]
14. Retroviral enhancer insertion 5' of c-myc in two translocation-negative mouse plasmacytomas upregulates c-myc expression to different extents. Shaughnessy JD, Owens JD, Wiener F, Hilbert DM, Huppi K, Potter M, Mushinski JF. Oncogene; 1993 Nov 15; 8(11):3111-21. PubMed ID: 8414513 [Abstract] [Full Text] [Related]
15. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis. Busch K, Borkhardt A, Wössmann W, Reiter A, Harbott J. Haematologica; 2004 Jul 15; 89(7):818-25. PubMed ID: 15257933 [Abstract] [Full Text] [Related]
16. Constitutive activation of oncogenes by chromosomal translocations in B-cell derived tumors. Klein G. AIDS Res; 1986 Dec 15; 2 Suppl 1():S167-76. PubMed ID: 3030345 [Abstract] [Full Text] [Related]
17. The t(8; 14) chromosomal translocation occurring in B-cell malignancies results from mistakes in V-D-J joining. Haluska FG, Finver S, Tsujimoto Y, Croce CM. Nature; 1986 Dec 15; 324(6093):158-61. PubMed ID: 3097550 [Abstract] [Full Text] [Related]
18. A novel c-myc-activating reciprocal T(12;15) chromosomal translocation juxtaposes S alpha to Pvt-1 in a mouse plasmacytoma. Shaughnessy J, Wiener F, Huppi K, Mushinski JF, Potter M. Oncogene; 1994 Jan 15; 9(1):247-53. PubMed ID: 8302586 [Abstract] [Full Text] [Related]
19. Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice. Wang Y, Sugiyama H, Axelson H, Panda CK, Babonits M, Ma A, Steinberg JM, Alt FW, Klein G, Wiener F. Oncogene; 1992 Jun 15; 7(6):1241-7. PubMed ID: 1375720 [Abstract] [Full Text] [Related]
20. Location of Myc, Igh, and Igk on Robertsonian fusion chromosomes is inconsequential for Myc translocations and plasmacytoma development in mice, but Rb(6.15)-carrying tumors prefer Igk-Myc inversions over translocations. Silva S, Wiener F, Klein G, Janz S. Genes Chromosomes Cancer; 2005 Apr 15; 42(4):416-26. PubMed ID: 15645495 [Abstract] [Full Text] [Related] Page: [Next] [New Search]